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MyD88: An Adapter That Recruits IRAK
to the IL-1 Receptor Complex
has been well characterized, the receptor proximal sig-
naling mechanisms for the various cytokines remain un-
defined. The elucidation of the IL-1 signaling pathway
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just began within the past few years. The first signaling*Tularik, Incorporated
event for IL-1 is a ligand-induced complex formation of2 Corporate Drive
the type I receptor (IL-1RI) and the receptor accessorySouth San Francisco, California 94080
protein (IL-1RAcP) (Greenfeder et al., 1995; Huang et²Genentech, Incorporated
al., 1997; Korherr et al., 1997; Wesche et al., 1997). The460 Point San Bruno Boulevard
serine/threonine IL-1 receptor±associated kinase (IRAK)South San Francisco, California 94080
is then recruited to the receptor complex, where it be-
comes highly phosphorylated (Cao et al., 1996a; Yamin
and Miller 1997). IRAK then leaves the receptor complexSummary
and interacts with TRAF6, which is required for IL-1±
induced NF-kB activation (Cao et al., 1996b). Two otherIL-1 is a proinflammatory cytokine thatsignals through
members of the TRAF (TNF-receptor associated factor)a receptor complex of two different transmembrane
family, TRAF2 and TRAF5, have been implicated in NF-chains to generate multiple cellular responses, includ-
kB activation signaledby the tumor necrosis factor (TNF)ing activation of the transcription factor NF-kB. Here
receptor superfamily (Rothe et al., 1995; Hsu et al.,we show that MyD88, a previously described protein
1996a, 1997; Ishida et al., 1996; Lee et al., 1996; Nakanoof unknown function, is recruited to the IL-1 receptor
et al., 1996; Aizawa et al., 1997; Duckett et al., 1997).complex following IL-1 stimulation. MyD88 binds to
These findings indicate that signaling pathways for dif-both IRAK (IL-1 receptor±associated kinase) and the
ferent NF-kB-activating cytokines may converge at theheterocomplex (the signaling complex) of the two
TRAF molecules.receptor chains and thereby mediates the association
Recently, a kinase complex consisting of the NF-kB±of IRAK with the receptor. Ectopic expression of
inducing kinase (NIK) and two IkB kinases (IKKa andMyD88 or its death domain±containing N-terminus ac-
IKKb) have been implicated in signal-induced phosphor-tivates NF-kB. The C-terminus of MyD88 interacts with
ylation of the IkB proteins (Di Donato et al., 1997; Malininthe IL-1 receptor and blocks NF-kB activation induced
et al., 1997; Mercurio et al., 1997; Regnier et al., 1997;by IL-1, but not by TNF. Thus, MyD88 plays the same
Woronicz et al., 1997; Zandi et al., 1997). NIK interactsrole in IL-1 signaling as TRADD and Tube do in TNF
with the TRAF proteins (Malinin et al., 1997; Song et al.,
and Toll pathways, respectively: it couples a serine/
1997), and IKKs phosphorylate IkB proteins on specific
threonine protein kinase to the receptor complex.
serine residues. Thus, this kinase cascade constitutes
a section of the signaling pathways distal to the TRAF
Introduction molecules.
IL-1RI and IL-1RAcP share an overall 25% sequence
Interleukin-1 (IL-1) participates in defense response to identity. Both belong to a conserved family of receptor-
environmental challenges by generating fever, activat- like molecules, including IL-1Rrp, IL-1Rrp2, T1/ST2,
ing lymphocytes, and promoting infusion of leukocytes rsc786/TIL, and human Toll in mammals (Yanagisawa
into the sites of injury or infection (reviewed by Dinarello, et al., 1993; Lovenberg et al., 1996; Mitcham et al., 1996;
1996). IL-1 exerts most of its activities by activating the Parnet et al., 1996; Medzhitov et al., 1997); RPP5 in
transcription of genes encoding chemokines, cytokines, plants (Parker et al., 1997); and 18 Wheeler and Toll in
acute-phase proteins, cell adhesion molecules, and en- Drosophila melanogaster (Hashimoto et al., 1988; Eldon
zymes involved in the production of small proinflamma- et al., 1994). Among these molecules, the Toll signaling
tory substances (reviewed by Dinarello, 1996; Barnes pathway was, for a long time, the best characterized.
and Karin, 1997). One important intracellular mediator The Toll pathway is required for activation of the antifun-
of the IL-1 response is nuclear transcription factor kB gal peptide drosomycin in response to microorganism
(NF-kB) (reviewed by Baeuerle and Baltimore, 1996; challenges (Lemaitre et al., 1996). This pathway also
Baldwin, 1996; Dinarello, 1996; Barnes and Karin, 1997), controls dorsal±ventral polarization during early embry-
which is rendered inactive in the cytoplasm by the in- onic development (reviewed by Wasserman, 1993; Mori-
hibitory proteins called IkB in unstimulated cells. Upon sato and Anderson, 1995; Belvin and Anderson, 1996;
exposure of cells to cytokines and other extracellular Norris and Manley, 1996). Analogous to IL-1 signaling,
stimuli, the IkB proteins are phosphorylated on specific activation of the cell surface receptor Toll by the extra-
serine residues and rapidly degraded, leading to nuclear cellular ligand Spaetzle leads to the phosphorylation
localization and activationof NF-kB (reviewed by Baeuerle and degradation of the IkB-like molecule Cactus, releas-
and Henkel, 1994; Siebenlist et al., 1994; Thanos and ing the NF-kB±like transcription factor Dorsal to enter
Maniatis, 1995; Verma et al., 1995). the nucleus, where it regulates gene expression. Dorsal
Although the biochemical process of NF-kB activation activation signaled by Toll requires two intermediate
signal transducers, Tube and Pelle (Letsou et al., 1993;
Shelton and Wasserman, 1993). Pelle is a serine/threo-³To whom correspondence should be addressed (e-mail: cao@
tularik.com). nine kinase that is related by sequence to IRAK, whereas
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Tube is an adapter molecule that tethers Pelle to the
plasma membrane (Grosshans et al., 1994; Galindo et
al., 1995). Tube and Pelle interact through their N-termi-
nal death domains, a protein±protein interaction domain
found in many signaling molecules, including IRAK
(Feinstein et al., 1995; Galindo et al., 1995; Cao et al.,
1996a). Because of the similarities found at multiple lev-
els in the signaling pathways initiated by Toll and IL-1R,
they probably evolved from the same ancestral signaling
mechanism and probably use conserved intermediate
components. However, to date, the mammalian homo-
log of Tube has not been identified.
Here we report the identification of MyD88, a pre-
viously described myeloid differentiation marker (Lord
et al., 1990), as a signaling molecule for IL-1. We show
that MyD88 is recruited to the IL-1 receptor complex by
IL-1 and functions as an adapter to recruit IRAK. Thus,
MyD88 represents a functional mammalian analog of
Drosophila Tube. Moreover, the role of MyD88 in IL-1
signaling is similar to that of the TNF signaling molecule
TRADD (type 1 TNF receptor±associated death domain
protein), which recruits the kinase RIP (receptor-inter-
acting protein) to the type I TNF receptor complex (Hsu
et al., 1995). These findings reveal that two cytokines
with similar biological functions, IL-1 and TNF, use anal-
ogous signaling mechanisms to generate cellular re-
sponses.
Results
Identification of MyD88 in the IL-1
Receptor Complex
To identify potential novel signaling proteins in the IL-1
receptor complex, we generated a human embryonic
kidney epithelial 293 cell line (293IL-1RI/AcP) stably ex-
pressing Myc-epitope±tagged IL-1RI and Flag-epitope±
tagged IL-1RAcP. These cells have higher basal NF-kB
activity but still respond to IL-1 with a further increase
Figure 1. Identification of MyD88 in the IL-1 Receptor Complexin NF-kB activation (data not shown). The 293IL-1RI/
(A) Coprecipitation of a 35 kDa protein with the IL-1 receptor com-AcP cells were metabolically labeled with [35S]methio-
plex. 293IL-1RI/AcP cells were metabolically labeled with 35S-radio-nine and cysteine and treated for 3 min with IL-1 or left
labeled amino acids, stimulated with IL-1b (3 min, 200 ng/ml), oruntreated before harvesting. Aliquots of cell extracts
left untreated. Cell lysates were subjected to immunoprecipitationwere immunoprecipitated with polyclonal antibodies to with normal rabbit serum (NRS), polyclonal antisera raised against
IRAK, TRAF6, or the extracellular domain of IL-1RI, or huIL-1RI, IRAK, or huTRAF6, and MAb specific for the Flag epitope
with anti-Flag monoclonal antibodies (MAb). Autoradi- that was tagged on IL-1RAcP. Immunoprecipitates were separated
by SDS-PAGE and labeled proteins were visualized by autoradiogra-ography of the immunoprecipitates separated on a so-
phy. Arrow, the 35 kDa protein coprecipitating with IL-1RI, IL-1RAcP,dium dodecyl sulfate (SDS) gel revealed a 35 kDa protein
and IRAK.(p35) coprecipitating with IL-1RI, IL-1RAcP, and IRAK
(B) Purification of p35. Equal amounts of untreated or IL-1±induced
in an IL-1±dependent manner (Figure 1A). p35 was not 293IL-1RI/AcP cells were lysed and the extracts immunoprecipi-
detected in the immunoprecipitates of normal rabbit tated with the M2 beads. Immunocomplexes were eluted with the
serum or TRAF6 antiserum. Because IL-1RI, IL-1RAcP, Flag peptide, separated by SDS-PAGE, and stained with Coomassie
brilliant blue. The positions of IL-1RI, IL-1RAcP, p35, and IL-1 areand IRAK form a biochemically detectable complex
indicated.upon IL-1 treatment (Huang et al., 1997), whereas TRAF6
(C) IL-1±induced association of MyD88 with the IL-1 receptor com-is not stably associated with this complex (Cao et al.,
plex. IL-1 receptor complexes from lysates of IL-1±treated (200 ng/
1996b), p35 represented a good candidate for a recep- ml IL-1b, 5 min) and untreated 293IL-1RI cells were immunoprecipi-
tor-associated signaling molecule. tated with anti IL-1RI antiserum and immunoblotted with antiserum
To purify p35, protein extracts from untreated or to MyD88 (top). Western analysis of the same blot with antiserum
to IL-1RI indicates that similar amounts of IL-1RI were immunopre-IL-1±treated 293IL-1RI/AcP cells were precipitated with
cipitated from untreated and IL-1±treated cells (bottom).anti-Flag antibody immobilized on sepharose (M2 beads).
After extensive washing, the precipitated IL-1RAcP
complex was eluted with Flag peptide, concentrated,
and resolvedby SDS polyacrylamide gel electrophoresis
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Figure 2. NF-kB Activation by MyD88
HeLa cells (1 3 105) were transfected with 0.5 mg of pELAM-luc reporter gene plasmid, 1 mg of pRSV-b-gal, and different amounts of expression
plasmids for either full-length MyD88 (A), MyD88-N (amino acids 1±151) (B), or MyD88-C (amino acids 152±296) (C). Forty hours after transfection
cells were left untreated or were stimulated for 8 hr with IL-1b (20 ng/ml) or TNF (100 ng/ml). Luciferase activities were determined and
normalized on the basis of b-galactosidase activity. Data shown are from one of five independent experiments with similar results.
(SDS-PAGE). Coomassie blue staining revealed three of mammalian expression plasmids for MyD88 activated
a cotransfected NF-kB±dependent luciferase gene in abands showing increased intensity upon IL-1 treatment:
p35, a diffuse band of 70±80 kDa corresponding to IL- dose-dependent manner (Figure 2A). Treatment of the
transfected cells with IL-1 or TNF further enhanced the1RI and IL-1RAcP, which are similar in size after glyco-
sylation, and a 17 kDa protein that is identical in size to luciferase activity. We next sought to determine which
portion of MyD88 protein is required for the observedIL-1 (Figure 1B).
The p35 protein was digested with lysine C and the activity. Expression of the N-terminal 151 amino acids of
MyD88 (MyD88-N), including the death domain, elicitedresulting peptides were separated by high-performance
liquid chromatography. A search of a protein sequence NF-kB activation similar to that by the full-length protein
(Figure 2B). However, the C-terminal half (amino acidsdatabase by peptide mass fingerprinting (Henzel et al.,
1993) matched p35 with a known protein, designated 152±296, MyD88-C), including the IL-1 receptor homol-
ogy domain, not only failed to activate NF-kB but alsoMyD88, with a calculated mass of 33 kDa. This identity
was verified by sequence analysis of a peptide with a specifically blocked the NF-kB activation by IL-1, yet
had no effect on NF-kB activation by TNF. This specificmass of 2832.1 (LCVXDRDVLP) and post±source decay
analysis (Kaufmann et al., 1994) of a peptide with a dominant negative effect of MyD88 C-terminus on IL-1
signaling further indicates that MyD88 is a componentmass of 1255.8. To confirm the peptide analysis and
sequencing results, the receptor complexes were immu- in the IL-1 pathway.
noprecipitated with antiserum to IL-1RI from untreated
or IL-1±treated 293IL-1RI cells and immunoblotted with Association of MyD88 with the IL-1
antiserum to MyD88. A 35 kDa band reactive to the Receptor Complex
specific antiserum was detected in the receptor com- To investigate the role of MyD88 in IL-1 signaling, we
plex derived from IL-1 treated but not untreated cells determined the kinetics of IL-1±induced MyD88 recruit-
(Figure 1C), indicating that p35 is indeed MyD88. ment to the IL-1 receptor complex. The receptor com-
plexes in 293IL-1RI/AcP cells stimulated with IL-1 for
various lengths of time were immunoprecipitated withIdentification of MyD88 as an IL-1
Signaling Molecule anti-IL-1RI antiserum and immunoblotted with antise-
rum to MyD88. MyD88 was detected 30 s after the IL-1MyD88 was first identified as a myeloid differentiation
primary response gene (Lord et al., 1990). Its expression treatment, and the amounts of the protein increased
slightly but steadily over the next 10 min (Figure 3A,was subsequently detected in a variety of nonmyeloid
tissues, indicating that the protein might have a broader top). This result indicates that IL-1±induced association
of MyD88 with the receptor complex is rapid and rela-biological function (Hardiman et al., 1996; Bonnert et
al., 1997). By sequence analysis, the protein contains tively stable. On the other hand, immunoblotting of the
same membrane with antiserum to IRAK indicates thattwo functional domains, an N-terminal death domain
and a C-terminal domain homologous to the cyto- the interaction of IRAK with the receptor complex is
rapid but transient. In this cell line, the amounts of recep-plasmic tails of the IL-1 receptor family (Hultmark, 1994;
Hardiman et al., 1996). Although it has been reported tor-associated IRAK peaked 30 s after IL-1 induction,
followed by a steep decline (Figure 3A, bottom). Thisthat ectopic expression of MyD88 activates an NF-kB±
dependent IL-8 gene promoter in cos7 cells (Bonnert result agrees with our earlier speculation that interaction
of IRAK with the downstream TRAF6 occurs in the cyto-et al., 1997), its biological role remains unclear. The
detection of MyD88 in the activated IL-1 receptor com- plasm off the receptor complex (Cao et al., 1996b). A
mobility shift of IRAK that reflects autophosphorylationplex provided biochemical evidence that MyD88 might
participate in IL-1 signal transduction. We then used the was evident 30 s after IL-1 treatment (unphosphorylated
IRAK runs as an 80 kDa band in an SDS gel [Cao et al.,luciferase reporter assay to investigate the functional
role of MyD88 in IL-1±induced NF-kB activation. 1996a]). A further shift of mobility was observed at later
time points.Transient transfection of 293 cells with small amounts
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Figure 3. Interaction of MyD88 with the IL-1 Receptor Complex
(A) Kinetics of IL-1±induced MyD88 and IRAK association with the IL-1 receptor complex. 293IL-1RI/AcP cells (6 3 107) were stimulated with
200 ng/ml IL-1b for the indicated times. IL-1 receptor complexes from cell lysates were immunoprecipitated with an anti-IL-1RI antiserum
and immunoblotted with antiserum to MyD88 (top) and IRAK (bottom).
(B) Interaction of MyD88 with heterocomplexes of the receptor chains. 293 cells (3 3 106) in a 10 cm dish were transfected with the indicated
combinations of expression plasmids for Flag-tagged IL-1RI; IL-1RAcP; and Myc-tagged MyD88, MyD88-N (amino acids 1±151), or MyD88-C
(amino acids 152±296) (1 mg of each expression construct per transfection). After 24 hr, cell lysates were prepared and immunoprecipitations
were performed with anti-Flag MAb. Coprecipitating Myc-tagged MyD88 was detected with anti-Myc antiserum (top). Immunoblotting the
same membrane with anti-Flag MAb indicates that similar amounts of the receptor chains were immunoprecipitated (middle). Lysates of the
transfected cells were immunoblotted with Anti-Myc antiserum to monitor the expression of MyD88 (bottom).
IL-1 signal transduction requires both IL-1RI and IL- even when the two chains were coexpressed. The
C-terminal half, however, bound weakly to IL-1RI alone1RAcP, which form a heterocomplex upon IL-1 treat-
ment (Greenfeder et al., 1995; Huang et al., 1997). To but bound with high affinity to the IL-1RI and IL-1RAcP
heterocomplex (Figure 3B), indicating that the receptorunderstand the mechanism by which MyD88 is recruited
to the receptor complex, we examined the binding affin- homology region of MyD88 is responsible for its interac-
tion with the IL-1 receptor complex.ity of MyD88 to IL-1RI, IL-1RAcP, and the heterocomplex
of these two receptor chains. 293 cells were transiently
transfected with expression plasmids for Myc epitope± Inability of Inactive Receptor Mutants
to Bind to MyD88tagged MyD88 with expression plasmids for N-terminal
(extracellular) Flag-tagged IL-1RI and IL-1RAcP. The The intracellular domains of both IL-1RI and IL-1RAcP
are required for IL-1 signal transduction (Curtis et al.,receptor complexes were immunoprecipitated with anti-
Flag antibody and immunoblotted with anti-Myc anti- 1989; Heguy et al., 1992; Kuno et al., 1993; Leung et al.,
1994; Huang et al., 1997). Deletion of 45 amino acidsbody. MyD88 coprecipitated with neither IL-1RI nor
IL-1RAcP when they were individually expressed but from the C-terminus of the IL-1RI abolishes the ability
of the receptor to signal (Croston et al., 1995). Similarly,was readily detectable in anti-Flag immunoprecipitates
from cells that expressed both receptor chains (Figure removal of 37 amino acids from the C-terminus of IL-
1RAcP creates a loss-of-function mutant (data not3B). When IL-1RI and IL-1RAcP are transiently coex-
pressed in 293 cells, they form a functional complex shown). Overexpression of either IL-1RID45 or IL-
1RAcPD37 also inhibits IL-1±induced NF-kB activationable toactivate NF-kB (Huanget al., 1997). The observed
high affinity of MyD88 to the heterocomplex of receptors in a reporter assay (Figure 4A). This result indicates
that the mutants are still capable of binding ligand andprovides a mechanism for IL-1±dependent recruitment
of MyD88. forming a receptor complex.
To investigate whether these receptor mutants fail toTo determine which domain of MyD88 is responsible
for its receptor association, we tested whether MyD88-N signal because they can no longer recruit MyD88, we
tested whether receptor complexes containing IL-1RID45or MyD88-C is able to bind to the receptor complex,
using the same experimental procedure. The N-terminal and IL-1RAcPD37 can bind to MyD88. 293 cells were
transfected with expression plasmids for Myc-taggedhalf of MyD88 did not coprecipitate with the receptors
MyD88 in IL-1 Signal Transduction
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Figure 4. Interaction of MyD88 with the Functional Receptor Complex
(A) Inhibition of IL-1±induced NF-kB activation by IL-1RID45 (left) and IL-1RAcPD37 (right). HeLa cells were transfected with 0.5 mg of pELAM-
luc reporter gene plasmid; 1 mg of pRSV-b-gal; and varied amounts of expressions plasmids for either IL-1RI, IL-1RID45, IL-1RAcP, or IL-
1RAcPD37 as indicated. Forty hours after transfection cells were either left untreated or were stimulated for 8 hr with IL-1b (20 ng/ml).
Luciferase activities were determined and normalized on the basis of b-galactosidase activity. Similar results were obtained from four
independent experiments.
(B) Inability of MyD88 to coprecipitate with receptor mutants. 293 cells (3 3 106) were transfected with 1 mg of expression plasmids for Myc-
tagged MyD88 in combination with Flag-tagged wild-type and mutant IL-1RI and IL-1RAcP as indicated. After 24 hr, cell lysates were prepared
and immunoprecipitated with anti-Flag MAb. Coprecipitating Myc epitope±tagged MyD88 was detected using Myc antiserum (top). Western
analysis of the same blot with MAb to the Flag epitope indicates that similar amounts of the receptor chains were immunoprecipitated (middle).
Immunoblot analysis of total cell extracts with anti-Myc antiserum shows that equal amounts of MyD88 were expressed (bottom).
MyD88 with various combinations of the Flag-tagged and receptor molecules in cells. To test this idea, the
various MyD88 expression vectors were transfected intowild-type receptor chains, IL-1RID45, and IL-1RAcPD37.
293IL-1RI cells. After 36 hr, the cells were treated for 5Compared with the amountsof MyD88 coprecipited with
min with IL-1 or left untreated and lysed. The extractsthe wild-type receptors, only very weak binding of
were immunoprecipitated with anti-IL-1RI antiserumMyD88 was detected in receptor complexes containing
and the precipitates immunoblotted to detect IRAK.one or both loss-of-function mutants, establishing a cor-
Compared with the amounts of IRAK in the receptorrelation of receptor function and their ability to interact
complex in cells transfected with an empty vector, re-with MyD88 (Figure 4B).
duced amounts of IRAK were detected in the receptor
complex from cells expressing the full-length protein,Interaction of the IL-1R Complex with IRAK
the N-terminal half, and the C-terminal half of MyD88Mediated by MyD88
(Figure 5B). Considering that transfection efficiency withBecause both MyD88 and IRAK coprecipitate with the
293 cells is typically 50%±75%, the actual blocking ef-receptor complex in an IL-1±dependent manner (Figures
fect of MyD88 on IRAK binding to the receptors is proba-1C and 3A), we investigated whether MyD88 might play
bly far greater than represented here.the role of an adapter for IRAK. Flag-tagged full-length
To examine directly whether MyD88 can mediate theor truncational mutants of MyD88 were coexpressed
association of IRAK and IL-1R, we transiently coex-in 293 cells with either wild-type or a kinase-defective
pressed the two Flag-tagged receptor chains with IRAKmutant of IRAK (IRAK K239S). Immunoblotting analysis
or IRAK K239S in the presence or absence of MyD88.
of the anti-Flag immunoprecipitates showed that the
Immunoprecipitation with anti-Flag antibody copre-
full-length protein and the N- and C-terminal portions
cipitated IRAK K239S only in the presence of MyD88
of MyD88 each can bind to the kinase defective form (Figure 5C). The phosphorylated kinase active IRAK
of IRAK. that did not bind to MyD88 (Figure 5A) also did not
Of note, MyD88 did not coprecipitate the kinase- coprecipitate with the receptor chains even in presence
active form of IRAK, which is spontaneously autophos- of MyD88. These results indicate that MyD88 is an
phorylated upon overexpression, as evidenced by its intermediate signaling molecule linking IRAK and the
retarded mobility in an SDS gel (Figure 5A, bottom). receptor complex.
Because endogenous IRAK remains underphosphory-
lated until it is recruited into the receptor complex (Cao The Hierarchy of MyD88, IRAK, and TRAF6
et al., 1996a), the high affinity of MyD88 for underphos- in IL-1 Signaling Pathway
phorylated IRAK is consistent with its role as an adapter The biochemical evidence presented above suggests
for recruiting IRAK. In addition, the inability of MyD88 that MyD88 couples IRAK to the receptor and therefore
to bind to phosphorylated IRAK may explain how IRAK functions upstream of IRAK. We used the reporter gene
leaves the receptor complex after its phosphorylation. assay to examine this hierarchy. Overexpression of the
If MyD88 is an adapter for IRAK, then overexpression N-terminal 215 amino acids of IRAK (IRAK-N) and the
of MyD88 should reduce the amounts of endogenous C-terminus of TRAF6 (amino acids 289±522, DTRAF6)
IRAK coprecipitating with the IL-1 receptor complex inhibited IL-1±induced NF-kB±dependent luciferase ac-
tivity in 293IL-1RI cells (Figure 6A) (Cao et al., 1996b).upon IL-1 stimulation, given the limiting amounts of IRAK
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Figure 5. IRAK/Receptor Interaction Mediated by MyD88
(A) Coprecipitation of MyD88 and IRAK. 293 cells (3 3 106) were transfected with 2 mg of expression plasmid for Flag-tagged MyD88, MyD88-N
(amino acids 1±151), or MyD88-C (amino acids 152-296) alone or together with 3 mg of expression plasmid for wild-type IRAK or IRAK K239S.
After 24 hr, cell lysates were prepared and immunoprecipitated with anti-Flag MAb. Coprecipitating IRAK was detected using an IRAK antiserum
(top). Western analysis of the same blot with MAb to the Flag epitope shows that similar amounts of MyD88 were immunoprecipitated (middle).
The lysates of the transfected cells were immunoblotted with IRAK antiserum to monitor the expression of IRAK (bottom).
(B) Influence of MyD88 overexpression on IL-1±induced recruitment of endogenous IRAK to the IL-1 receptor complex. 293IL-1RI cells (3 3
106) were transfected with 2 mg of empty vector or expression plasmid for Flag-tagged MyD88, MyD88-N (amino acids 1±151) or MyD88-C
(amino acids 152±296) as indicated. IL-1 receptor complexes from lysates of IL-1 treated (200 ng/ml IL-1b, 5 min) and untreated cells were
immunoprecipitated with an anti±IL-1RI antiserum and immunoblotted with IRAK antiserum (top). Western analysis of the same blot with
antiserum to IL-1RI indicates that similar amounts of IL-1RI were immunoprecipitated (bottom).
(C) IRAK/receptor interaction through MyD88. 293 cells were transiently transfected with expression plasmids for Flag-tagged IL-1RI and IL-
1RAcP in various combinations with expression plasmids for IRAK, IRAK K239S, and Myc-tagged MyD88 as indicated. The receptor complexes
were precipitated with anti-Flag M2 beads, separated on an SDS gel, and immunoblotted with antiserum to IRAK (top). The expression of
IRAK (middle) and MyD88 (bottom) was verified by immunoblotting analysis of the cell lysates.
When IRAK-N or DTRAF6 was coexpressed with MyD88, further, we tested whether the dominant negative mu-
tant MyD88-C or DTRAF6 could block IRAK-induced NF-NF-kB activation by MyD88 was essentially abolished,
suggesting that MyD88 signals through IRAK and TRAF6 kB activation. Transient expression of IRAK induced a
mild, 5- to 6-fold NF-kB activation. Coexpression of(Figure 6B). To examine this order of signaling events
Figure 6. Hierarchy of MyD88, IRAK, and TRAF6 in IL-1 Signaling
(A) Dominant negative effect of MyD88-C, N-IRAK, and DTRAF6 on IL-1±induced NF-kB activation. 293 cells (1 3 105) were transfected with
0.5 mg of pELAM-luc reporter gene plasmid, 1 mg of pRSV-b-gal, and different amounts of expression plasmids for MyD88-C, N-IRAK, or
DTRAF6 as indicated. Twenty hours after transfection, cells were left untreated or were stimulated for 8 hr with IL-1b (20 ng/ml). Luciferase
activities were determined and normalized on the basis of b-galactosidase activity.
(B) Abrogation of MyD88-induced activation of NF-kB by N-IRAK and DTRAF6. 293 cells were transfected with 0.5 mg of pELAM-luc reporter
gene plasmid, 1 mg of pRSV-b-gal, 0.3 mg of a vector encoding MyD88, and varied amounts of expression plasmids for N-IRAK or DTRAF6
as indicated. Reporter assays were performed as described for (A).
(C) Effects of MyD88-C and DTRAF6 expression on IRAK-induced NF-kB activation. 293 cells were transfected with 1 mg of IRAK expression
plasmid with the indicated amounts of MyD88-C and DTRAF6 expression vectors. Reporter assays were carried out as described for (A).
Three independent experiments produced similar results.
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DTRAF6 counteracted this IRAK effect in a dose-depen-
dent manner. In contrast, MyD88-C, which dramatically
blocked IL-1±induced NF-kB activation (Figures 2C and
6A), exerted no effect on IRAK activity, a result consis-
tent with the notion that MyD88 functions upstream of
IRAK.
Discussion
IL-1 is a potent NF-kB activator that signals through
two related receptor chains, IL-1RI and IL-1RAcP. Both
proteins contain large cytoplasmic domains (212 and
187 amino acids for IL-1RI and IL-1RAcP, respectively)
that are required for signaling (Curtis et al., 1989; Heguy
et al., 1992; Kuno et al., 1993; Leung et al., 1994; Huang
et al., 1997). Neither receptor chain possesses enzy-
matic activity, so they must engage other intracellular
molecules to transduce IL-1 signals. We have previously
identified the serine/threonine kinase IRAK, which is re-
cruited to the receptor complex upon IL-1 induction
(Cao et al., 1996a). The recruitment of IRAK requires the
intracellular domains of both receptor chains. Receptor
molecules with mutations in their intracellular domains
failed to recruit IRAK and to signal (Croston et al, 1995;
Huang et al., 1997) (Figure 4). However, because these Figure 7. Receptor Proximal Signaling Pathway for IL-1 and TNF
experiments were performed in mammalian cells, it was
difficult to assess whether IRAK binds to the receptor
The identification of MyD88 as an adapter moleculechains directly or is recruited by an adapter molecule.
that recruits IRAK to the receptor complex extends theGivenour knowledge about theToll pathway inDrosoph-
conservation found in the signaling pathways for IL-1ila, which is analogous to the IL-1 pathway at the levels
and TNF, two major NF-kB±activating cytokines (Figureof the receptor (Toll, IL-1RI, and IL-1RAcP), intermediate
7). Whereas IL-1 signals through two different receptorkinase (Pelle and IRAK), and downstream targets (Cac-
chains, TNF signals by trimerizing the type 1 TNF re-tus/Dorsal and IkB/NF-kB), it seemed likely that IRAK
ceptor (TNFR1), which contains an intracellular deathis recruited to the receptor complex through an adapter
domain (Tartaglia and Goeddel, 1992). The TNFR1 com-molecule like Tube.
plex then recruits the 34 kDa death domain±containingBy metabolic cell labeling, we detected a 35 kDa pro-
molecule TRADD through homophilic interactions of thetein coprecipitating with IL-1RI, IL-1RAcP, and IRAK,
death domain (Hsu et al., 1995). TRADD mediates twothree known components of the active IL-1 receptor
major TNF responses: NF-kB activation and apoptosis.complex. Peptide sequencing and immunobotting with
To cause cell death, TRADD interacts with FADD tospecific antiserum indicated that p35 is MyD88 (Figure
trigger the apoptotic protease cascades (Boldin et al.,1C), a known protein with unknown function. We present
1996; Grimm et al., 1996; Hsu et al., 1996a; Muzio et al.,several lines of evidence supporting the role of MyD88
1996). To activate NF-kB, TRADD interacts with serine/as an IL-1 signal transducer. First, it binds exclusively
threonine kinase RIP and TRAF2, which ultimately feedto the heterocomplexes of IL-1RI and IL-1R1AcP (Figure
into the NIK/IKK cascade to trigger the phosphorylation3B), which form only after IL-1 treatment (Greenfeder et
and degradation of the IkB proteins (Hsu et al., 1996a,al., 1995; Huang et al., 1997). Second, it binds to the
1996b). Because MyD88 is responsible for recruitingwild-type receptor complex but not to the functionally
IRAK, which in turn interacts with TRAF6, it appears to becrippled complex in which either receptor chain has
the functional equivalent of TRADD in NF-kB activationbeen mutated by a truncation (Figure 4), suggesting that
signaled by IL-1.the binding to MyD88 is critical for receptor function.
Of note, the binding of MyD88 to IL-1 receptors isThird, both MyD88 and IRAK are detectable in the recep-
also mediated by a homophilic interaction through ator complex within seconds after IL-1 stimulation (Figure
conserved region, the IL-1 receptor homology domain,3A). Fourth, MyD88 binds to underphosphorylated IRAK
which is located in the cytoplasmic tail of the receptorand mediates its association with the receptor complex
chains and the C-terminus of MyD88. This region in IL-(Figure 5). Finally, the C-terminal half of MyD88 behaves
1RI is critical for IL-1 signal transduction, since muta-as a dominant negative mutant that inhibits NF-kB acti-
tions of this region abolishes the receptor functionvation induced by IL-1, but not by TNF (Figure 2). To-
(Croston et al., 1995). The N-terminal death domain ofgether, these data consistently indicate that MyD88 par-
MyD88 mediates NF-kB activation upon overexpressionticipates in IL-1 signaling by connecting the receptors
and binds to IRAK, suggesting that MyD88 signals bywith a downstream kinase, IRAK. Further support of
engaging IRAK through its death domain. Overexpres-this model comes from the results of luciferase reporter
sion of TRADD or the TRADD death domain that inter-assays, which indicate that MyD88 functions upstream
of IRAK and TRAF6 (Figure 6). acts with RIP also results in NF-kBactivation, once again
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et al., 1996a, 1996b; Huang et al., 1997). The control expressionrevealing conserved properties shared by the counter-
plasmid pRK5, the NF-kB±dependent E-selectin-luciferase reporterparts of the IL-1 and TNF pathways. However, binding
gene plasmid pELAM-luc, and pRSV-b-gal also have been describedof IRAK apparently is not sufficient for NF-kB activation
(Schall et al., 1990; Schindler and Baichwal, 1994; Rothe et al., 1995).
because the IRAK-binding MyD88 C-terminus is a domi- Expression vectors for N-terminal Flag-tagged IL-1RI, IL-1RID45,
nant negative mutant that inhibits IL-1±induced NF-kB and IL-1RAcPD37 were constructed by inserting polymerase chain
reaction (PCR)±generated cDNA fragments lacking the coding se-activation, suggesting that proper confirmation of the
quence for the signal peptide into the mammalian expression vectorMyD88 and IRAK complex is important for signaling.
pFlag-CMV-1 (Eastman Kodak Company, New Haven). The plasmidUnlike TRADD, however, ectopic expression of MyD88
encoding N-IRAK (amino acids 1±215) was generated by insertingdoes not cause cell death in 293 and HeLa cells (data
the PCR-amplified corresponding IRAK cDNA into pRK5. IRAK
not shown). Similarly, IL-1 does not signal apoptosis in K239S was constructed using the Quick-Change site-directed muta-
these cells. genesis kit (Stratagene, La Jolla). Expression vectors for epitope-
tagged MyD88 (Genbank accession number U84408), MyD88-NThe analogy between IL-1 and TNF signaling pathway
(amino acids 1±151), or MyD88-C (amino acids 152±296) were con-outlined above and in Figure 7 implies that RIP and IRAK
structed in-frame with a N-terminal Flag or Myc epitope or amay play the same role in NF-kB activation signaled by
C-terminal Flag epitope in pRK5.
TNF and IL-1, respectively. Although the two kinases
show no similarity at the level of primary sequence, both 293IL-1RI/AcP Cell Line
are recruited to the receptors by adapter molecules, 293IL-1RI cells (Cao et al., 1996a) were seeded in a 10 cm dish and
transfected with 5 mg of expression plasmid for N-terminal Flag-interact with TRAF proteins, and activate NF-kB when
tagged IL-1RAcP and 0.5 mg of plasmids containing a hygromycine-ectopically expressed in cells. Gene inactivation studies
resistance gene controlled by the SV40 promoter and enhancer byindicate that RIP is an essential molecule for TNF-
calcium phosphate precipitation (Ausubel et al., 1994). The cells
induced NF-kB activation (Ting et al., 1996). However, were cultured in DMEM with 100 mg/ml hygromycine B (Boehringer
the exact role of this molecule remains undefined. Eluci- Mannheim) until cell colonies were visible by eye. The colonies were
picked with pipette tips. The clones expressing the Flag-tagged IL-dation of the mechanistic role of IRAK in IL-1 signaling
1RAcP were identified by flow cytometry with anti-Flag MAb andmay shed light on RIP function, and vice versa.
propagated like regular 293 cells.The number of identified IL-1 receptor±related mole-
cules is rapidly increasing. To date, the biological func- Metabolic Cell Labeling
tions of most of them have not been clearly defined. 293IL-1RI/AcP cells were cultured in 10 cm dishes to 80% conflu-
However, IL-1Rrp has recently been shown to be the ence. The cells were washed once with phosphate-buffered saline
(PBS) and incubated in DMEM lacking methionine and cysteine withreceptor for an IL-1±related cytokine, IL-18, which
5% dialyzed fetal bovine serum and 200 mCi/ml [35S]methionine/synergizes with IL-12 to promote the production of
cysteine protein labeling mix (New England Nuclear) for 16 hr. Theinterferon-g by T cells (Okamura et al., 1995; Torigoe et
cells were collected with PBSwith 1 mM EDTA, pelleted by a 5 s spin
al., 1997). Like IL-1 and TNF, IL-18 also activates NF- in a microfuge, and resuspended in 378C DMEM. The cell suspension
kB (Robinson et al., 1997; Torigoe et al., 1997). Given was divided in two halves: one was treated with IL-1b (200 ng/ml)
the homophilic nature of the MyD88/IL-1±receptor inter- for 3 min and the other was left untreated. The cell lysate were
aliquoted and immunoprecipitated with antibodies as described be-action, it is possible that MyD88 or related molecules
low. The immunoprecipitates were boiled in SDS sample buffer,may participate in the signaling of other IL-1 receptor
separated on a 10% SDS gel, and exposed to x-ray film.family members. This is particularly true for IL-1Rrp be-
cause IL-18 stimulation of Th1 cells also activates IRAK Purification and Sequencing of p35
(Robinson et al., 1997). In this light, elucidation of the 293IL-1RI/AcP cells were cultured in suspension until a density of
500,000 cells/ml was reached. Cells from 40 liters of culture wereIL-1 pathway provides a starting point to understand
pelleted by a 5 min 500 3 g centrifugation and resuspended inthe signaling mechanisms for a large class of cytokine
prewarmed DMEM. Half of the cells were induced for 5 min withreceptors.
200 ng/ml IL-1b, and the other half were not induced. The cells were
lysed in lysis buffer (described below). The lysates were centrifuged
Experimental Procedures at 2000 3 g for 10 min, and the supernatants were centrifuged again
for 2 hr at 100,000 3 g in a Sorval Ti45 rotor. The supernatants were
Biological Reagents and Cell Culture mixed with the M2beads at 48C overnight. The beads were collected
Recombinant human IL-1b and TNFa were provided by Genentech in an empty column and washed with 20 column volumes of lysis
(South San Francisco). The anti-Flag MAb M2, M2 cross-linked to buffer followed by 20 volumes of lysis buffer containing 1 M NaCl.
sepharose beads (M2 beads), and purified Flag peptide were pur- The IL-1RAcP complex bound was eluted with three column vol-
chased from Eastman Kodak Company (New Haven). Rabbit anti- umes of lysis buffer with Flag peptide (200 mg/ml). The eluates were
Myc polyclonal antibodies were from Santa Cruz Biotechnology concentrated with Centricon 30 (Amicon) to 200 ml. The proteins
(Santa Cruz). Antiserum against IRAK and IL-1RI was raised in rab- were precipitated with 50 ml of ice-cold 100% (w/v) trichloroacetic
bits as described (Cao et al., 1996a; Croston et al., 1995). Polypep- acid with 4 mg/ml sodium deoxycholate, separated on a 4%±20%
tides containing the N-terminal 152 amino acids of MyD88 with a gradient SDSgel, and transferred to polyvinylidene difluoride (PVDF)
polyhistidine tag was expressed in Escherichia coli BL21, purified membrane. The protein bands were visualized by Coomassie blue
under denaturing conditions with nickel-coated beads as previously staining. The 35 kDa band was excised, alkylated with isopropyl-
described (Cao et al., 1996a), and used for generating antibodies acetamide, and digested in 20 ml of 0.05 M ammonium bicarbonate
in rabbits (Zymed, South San Francisco). Human embryonic kidney containing 1% Zwitergent 3±16 (Calbiochem) (Lui et al., 1996) with
293 cells and HeLa cells were maintained in Dulbecco's modified 0.2 mg of trypsin (Frozen Promega Modified) at 378C for 17 hr. The
Eagle's medium (DMEM) supplemented with 10% fetal calf serum, solution was then directly injected onto a 0.32 3 150 mm C18 capil-
100 mg/ml penicillin G, and 100 mg/ml streptomycin (Life Technol- lary column and subjected to sequencing as described (Hou et al.,
ogies). 1994).
Expression Vectors Reporter Assays
Mammalian expression vectors encoding N-terminal Flag-tagged For reporter gene assays, 1 3 105 293 or HeLa cells were seeded
into six-well (35 mm) plates. Cells were transfected the followingIL-1RAcP, IRAK, and DTRAF6 have been described elsewhere (Cao
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day by the calcium phosphate precipitation method with 0.5 mg Cao, Z., Henzel, W.J., and Gao, X. (1996a). IRAK: a kinase associated
with the interleukin-1 receptor. Science 271, 1128±1131.pELAM-luc, 1 mg (for 293 cells) or 2 mg pRSV-b-gal (for HeLa cells),
and the indicated amounts of expression constructs. After 24 hr (for Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., and Goeddel, D.V.
293 cells) or 46 hr (for HeLa cells), the cells were stimulated with (1996b). TRAF6 is a signal transducer for interleukin-1. Nature 383,
IL-1b (20 ng/ml) or with TNFa (100 ng/ml) for 8 hr before harvest. 443±446.
Luciferase activity and b-galactosidase activity were determined Croston, G.E., Cao, Z., and Goeddel, D.V. (1995). NF-kappa B activa-
with the Luciferase Assay System (Promega) and chemiluminescent tion by interleukin-1 (IL-1) requires an IL-1 receptor-associated pro-
reagents from Tropix, respectively. tein kinase activity. J. Biol. Chem. 270, 16514±16517.
Curtis, B.M., Gallis, B., Overell, R.W., McMahan, C.J., De Roos, P.,
Immunoprecipitations and Immunoblotting Ireland, R., Eisenman, J., Dower, S.K., and Sims, J.E. (1989). T-cell
For coprecipitation of transfected proteins, 3 3 106 293 cells were interleukin 1 receptor cDNA expressed in Chinese hamster ovary
plated on 10 cm dishes and transfected the following day with the cells regulates functional responses to interleukin 1. Proc. Natl.
indicated amounts of expression constructs. The total amount of Acad. Sci. USA 86, 3045±3049.
DNA was kept constant in each transfection by adding an empty
Di Donato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin,vector. After 24 hr, cells were collected, washed once with PBS,
M. (1997). A cytokine-responsive IkappaB kinase that activates theand lysed for 20 min on ice in 1 ml of lysis buffer containing 50 mM
transcription factor NF-kappaB. Nature 388, 548±554.HEPES (pH 7.9), 250 mM NaCl, 20 mM b-glycerophosphate, 1 mM
Dinarello, C.A. (1996). Biologic basis for interleukin-1 in disease.sodium orthovanadate, 5 mM p-nitrophenylphosphate, 2 mM dithio-
Blood 87, 2095±2147.threitol, protease inhibitors (Complete, Boehringer Mannheim), and
1% NP-40. Cellular debris was removed by centrifugation twice at Duckett, C.S., Gedrich, R.W., Gilfillan, M.C., and Thompson, C.B.
(1997). Induction of nuclear factor kappaB by the CD30 receptor is10,000 3 g for 15 min. Half of the cell lysate (0.5 ml) was incubated
mediated by TRAF1 and TRAF2. Mol. Cell. Biol. 17, 1535±1542.with 1 mg of the specific antibodies and 20 ml of 50% (v/v) protein
A-Sepharose slurry (Zymed, South San Francisco) or M2 beads Eldon, E., Kooyer, S., D'Evelyn, D., Duman, M., Lawinger, P., Botas,
(Eastman Kodak) for 2 hr at 48C with gentle rocking, while the other J., and Bellen, H. (1994). The Drosophila 18 wheeler is required for
half was incubated with an unrelated antibody and protein A-Sepha- morphogenesis and has striking similarities to Toll. Development
rose as controls (data not shown). After extensive washing with lysis 120, 885±899.
buffer, proteins bound to the beads were solubilized by boiling in Feinstein, E., Kimchi, A., Wallach, D., Boldin, M., and Varfolomeev,
SDS sample buffer, fractionated by SDS-PAGE, transferred to PVDF E. (1995). The death domain: a module shared by proteins with
membranes, and blotted with the indicated antibodies. The reactive diverse cellular functions [letter]. Trends Biochem. Sci. 20, 342±344.
bands were visualized with horseradish peroxidase coupled to the
Galindo, R.L., Edwards, D.N., Gillespie, S.K., and Wasserman, S.A.appropriate secondary antibodies with an enhanced chemilumines-
(1995). Interaction of the pelle kinase with the membrane-associatedcence Western blotting detection system (Amersham Life Science).
protein tube is required for transduction of the dorsoventral signal
in Drosophila embryos. Development 121, 2209±2218.
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